Rothschild & Co Redburn upgraded shares of Novozymes A/S (OTCMKTS:NVZMY – Free Report) to a strong-buy rating in a research note published on Friday morning,Zacks.com reports.
Novozymes A/S Stock Performance
Shares of NVZMY stock opened at $58.98 on Friday. The stock has a 50-day simple moving average of $59.32 and a 200 day simple moving average of $61.41. The stock has a market capitalization of $24.45 billion, a P/E ratio of 42.13, a P/E/G ratio of 1.07 and a beta of 1.11. Novozymes A/S has a fifty-two week low of $49.90 and a fifty-two week high of $75.99. The company has a quick ratio of 0.44, a current ratio of 0.72 and a debt-to-equity ratio of 0.12.
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.79 by ($0.44). Novozymes A/S had a return on equity of 6.37% and a net margin of 13.96%.The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.22 billion. On average, sell-side analysts expect that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Featured Articles
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
